Phenolic-glycolipid-1 and lipoarabinomannan preferentially modulate TCR- and CD28-triggered proximal biochemical events, leading to T-cell unresponsiveness in mycobacterial diseases

Lipids in Health and Disease

Beenu Joshi⁴  Utpal Sengupta⁴  Vishwa Mohan Katoch²  Naim Akhtar Khan³  Arshad Rizvi⁴  Bhavyata Dua⁴  Rajni Upadhyay⁴  Bhawna Sharma⁴  Pradeep Kumar Dagur¹ 

[1] Present address: Flow-Cytometry Core, NHLBI-NIH, Bethesda, MD, 20892, USA;Present address: Secretary, Department of Health Research and Director-General, ICMR, Ansari Nagar, New Delhi-29, India;UPRES EA 4183 Lipides & Signalisation Cellulaire, Université de Bourgogne, Faculté des Sciences de la vie, 6, Boulevard Gabriel, Dijon, 21000, France;Immunology Laboratory, National JALMA Institute for Leprosy and Other Mycobacterial Diseases (ICMR), Dr.M.Miyazaki Marg, Tajganj, Agra, 282001, India

关键词: Anergy;    T-cell activation;    Man-LAM;    PGL-1;    Mycobacteria;   

Others  :  1160199
DOI  :  10.1186/1476-511X-11-119

 received in 2012-05-13, accepted in 2012-09-05,  发布年份 2012

【 授权许可】

   
2012 Dagur et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Cosma CL, Sherman DR, Ramakrishnan L: The secret lives of the pathogenic mycobacteria. Annu Rev Microbiol 2003, 57:641-676.
• [2]Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN, Kaplan G, Barry CE III: A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004, 431:84-87.
• [3]Russel DG, Mwandumba HC, Rhoades EE: Mycobacteria and the coat of many lipids. J Cell Biol 2000, 158:421-426.
• [4]Nath I, Singh R: The suppressive effect of M. leprae on the in vitro proliferation responses of lymphocytes from patients with leprosy. Clin Exp Immunol 1980, 42:203-210.
• [5]Koster FT, Scollard DM, Umland E, Fishbein DB, Hanley WC, Brennan PJ, Nelson KE: Cellular and humoral immune responses to a phenolic glycolipid antigen (PhenGL-1) in patients with leprosy. J Clin Immunol 1987, 25:551-556.
• [6]Moreno C, Mehlert A, Lamb J: The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clin Exp Immunol 1988, 74:206-210.
• [7]Fournie JJ, Adams E, Mullins RJ, Basten A: Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect Immun 1989, 57:3653-3659.
• [8]Molloy AT, Gaudernack G, Levis WR, Cohn ZA, Kaplan G: Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide. Proc Natl Acad Sci USA 1990, 87:973-977.
• [9]Barnes PF, Chatterjee D, Abrams JS, Lu S, Wang E, Yamamura M, Brennan PJ, Modlin R: Cytokine production induced by Mycobacterium tuberculosis Lipoarabinomannan: relationship to structure. J Immunol 1992, 149:541-547.
• [10]Moura ACN, Mariano M: Lipids from M. leprae cell wall suppress T-cell activation in vitro and in vivo. Immunol 1997, 92:429-436.
• [11]Schwartz RH: Cell culture model for T lymphocyte clonal anergy. Science 1990, 248:1349-1356.
• [12]Zea AH, Cullota KS, Ali J, Mason C, Park HJ, Zabaleta J, Garcia LF, Ochoa AC: Decreased expression of CD3z and nuclear transcription factor kB in patiens with tubercolsis: potential mechanisms and reversibility with treatment. J Infect Dis 2006, 194:1385-1393.
• [13]Sharma N, Sharma VK, Gupta A, Kaur I, Kaur S, Ganguly NK: Alterations in early biochemical events following T-cell activation in leprosy patients. Clin Immunol Immunopathol 1998, 88:142-149.
• [14]Zea AH, Ochoa MT, Ghosh P, Longo DL, Moreno LH, Ochoa AC: Changes in expression of signal transduction proteins in T-lymphocytes of patients with leprosy. Infect Immun 1998, 66:499-504.
• [15]Chattree V, Khanna N, Rao DN: Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients. Mol Immunol 2007, 44:2066-2077.
• [16]Dagur PK, Sharma B, Kumar G, Khan NA, Katoch VM, Sengupta U, Joshi B: Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/CD28-induced signaling events: Insights into T-cell unresponsiveness in leprosy. Mol Immunol 2010, 47:943-952.
• [17]Mohagheghpour N, Gelber RH, Larrick JW, Sasaki DT, Brennan PJ, Engleman EG: Defective cell-mediated immunity in leprosy: failure of T-cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin-2 receptors and is not reconstituted by Interleukin-2. J Immunol 1985, 135:1443-1449.
• [18]Schwartz RH: Models of T-cell anergy: Is there a common molecular mechanism? J Exp Med 1996, 184:1-8.
• [19]Kim W, Khan NA, McMurray DN, Prior IA, Wang N, Chapkin RS: Regulatory activity of polyunsaturated fatty acids in T-cell signaling. Prog Lipid Res 2010, 49:250-261.
• [20]Mahon RN, Rojas RE, Fulton SA, Franko JL, Harding CV, Boom WH: Mycobacterium tuberculosis cell wall glycolipids directly inhibit CD4+ T-cell activation by interfering with proximal T-cell receptor signaling. Infect Immun 2009, 77:4574-4583.
• [21]Lewis R: Calcium signaling in T lymphocytes. Annu Rev Immunol 2001, 19:497-521.
• [22]Joshi B, Kedouchi S, Dagur PK, Hichami A, Sengupta U, Khan NA: On cell signalling mechanism of Mycobaterium leprae soluble antigen (MLSA) in Jurkat T-cells. Mol Cell Biochem 2006, 287:157-164.
• [23]Malik ZA, Denning GM, Klusner DJ: Inhibition of Ca2+ signalling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages. J Exp Med 2000, 191:287-302.
• [24]Malik ZA, Thompson CR, Hashimi S, Porter B, Iyer SS, Klusner DJ: Mycobacterium tuberculosis blocks Ca2+ signalling and phagosome maturation in human macrophages via specific inhibition of sphingosine kinase1. J Immunol 2003, 170:2811-2815.
• [25]Talreja J, Bhatnagar A, Jindal SK, Ganguly NK: Influence of Mycobacterium tuberculosis on differential activation of helper T-cells. Clin Exp Immunol 2003, 131:292-298.
• [26]Huse M: The T-cell-receptor signalling network. J Cell Sci 2009, 122:1269-1273.
• [27]Cantrell D: T-cell antigen receptor signal transduction pathways. Annu Rev Immunol 1996, 14:259-274.
• [28]Tapinos N, Rambukkana A: Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli. Proc Natl Acad Sci USA 2005, 102:9188-9193.
• [29]Sinsimer D, Huet G, Manca C, Tsenova L, Koo M-s, Kurepina N, Kan B, Mathema B, Marras SAE, Kreiswirth BN, Guilhot C, Kaplan G: The phenolic glycolipid of mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confers hypervirulence. Infect Immun 2008, 76:3027-3036.
• [30]Hickman SP, Yang J, Thomas RM, Wells AD, Turka LA: Defective activation of Protein Kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ Regulatory T-cells. J Immunol 2006, 177:2186-2194.
• [31]Garg A, Barnes PF, Ro S, Quiroga MF, Wu S, Garcia V, Kruktzik SR, Weis SE, Vankayalapati R: Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur J Immunol 2008, 38:459-469.
• [32]Waldmann TA: The multi-subunit interleukin-2 receptor. Annu Rev Biochem 1989, 58:875-911.
• [33]Antas PRZ, Oliveria EB, Milagres AS, Franken KC, Ottenhoff THM, Klatser P, Sarno EN, Sampaio EP: Kinetics of T-cell activation molecules in response to Mycobacterium tuberculosis antigens. Mem Inst Oswaldo Cruz Rio de Janerio 2002, 97:1097-1099.
• [34]Grynkiewicz G, Poenie M, Tsien RY: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260:3440-3450.
• [35]Kim J-E, White FM: Quantitative analysis of phosphotyrosine signalling networks triggered by CD3 and CD28 costimulation in Jurkat cells. J Immunol 2006, 176:2833-2843.
• [36]Schreiber E, Matthias P, Muller MM, Schaffner W: Rapid detection of octamer binding proteins with ’mini-extracts’, prepared from a small number of cells. Nucleic Acids Res 1989, 17:6419-6419.
• [37]Rooney JW, Hodge MR, McCaffrey PC, Rao A, Glimcher LH: A common factor regulates both Th1- and Th2-specific cytokine gene expression. EMBO J 1994, 13:625-633.